HEADER HYDROLASE/HYDROLASE INHIBITOR 29-MAR-15 4Z2B TITLE THE STRUCTURE OF HUMAN PDE12 RESIDUES 161-609 IN COMPLEX WITH TITLE 2 GSK3036342A COMPND MOL_ID: 1; COMPND 2 MOLECULE: 2',5'-PHOSPHODIESTERASE 12; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 155-609; COMPND 5 SYNONYM: 2-PDE,MITOCHONDRIAL DEADENYLASE; COMPND 6 EC: 3.1.4.-,3.1.13.4; COMPND 7 ENGINEERED: YES; COMPND 8 OTHER_DETAILS: TEV CLONING TAG ON N-TERMINUS SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PDE12; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 9 EXPRESSION_SYSTEM_VARIANT: DE3 KEYWDS PDE12 2'-5'A EEP NUCLEASE INHIBITOR COMPLEX, HYDROLASE-HYDROLASE KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR R.T.NOLTE,B.WISELY,L.WANG,E.R.WOOD REVDAT 4 27-SEP-23 4Z2B 1 JRNL REMARK REVDAT 3 19-AUG-15 4Z2B 1 JRNL REVDAT 2 24-JUN-15 4Z2B 1 JRNL REVDAT 1 17-JUN-15 4Z2B 0 JRNL AUTH E.R.WOOD,R.BLEDSOE,J.CHAI,P.DAKA,H.DENG,Y.DING, JRNL AUTH 2 S.HARRIS-GURLEY,L.H.KRYN,E.NARTEY,J.NICHOLS,R.T.NOLTE, JRNL AUTH 3 N.PRABHU,C.RISE,T.SHEAHAN,J.B.SHOTWELL,D.SMITH,V.TAI, JRNL AUTH 4 J.D.TAYLOR,G.TOMBERLIN,L.WANG,B.WISELY,S.YOU,B.XIA,H.DICKSON JRNL TITL THE ROLE OF PHOSPHODIESTERASE 12 (PDE12) AS A NEGATIVE JRNL TITL 2 REGULATOR OF THE INNATE IMMUNE RESPONSE AND THE DISCOVERY OF JRNL TITL 3 ANTIVIRAL INHIBITORS. JRNL REF J.BIOL.CHEM. V. 290 19681 2015 JRNL REFN ESSN 1083-351X JRNL PMID 26055709 JRNL DOI 10.1074/JBC.M115.653113 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.6 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 27.30 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 90.0 REMARK 3 NUMBER OF REFLECTIONS : 39837 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.183 REMARK 3 R VALUE (WORKING SET) : 0.182 REMARK 3 FREE R VALUE : 0.218 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.150 REMARK 3 FREE R VALUE TEST SET COUNT : 1255 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.85 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 89.99 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 1700 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2234 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1652 REMARK 3 BIN R VALUE (WORKING SET) : 0.2227 REMARK 3 BIN FREE R VALUE : 0.2505 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 2.82 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 48 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3532 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 59 REMARK 3 SOLVENT ATOMS : 462 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 20.62 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 21.79 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.41480 REMARK 3 B22 (A**2) : 0.12250 REMARK 3 B33 (A**2) : 0.29230 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.201 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.153 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.135 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.141 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.130 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.952 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.925 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 3743 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 5104 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1673 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 82 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 548 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 3743 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : 0 ; 5.000 ; SEMIHARMONIC REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 473 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 4786 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 0.98 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.99 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 2.52 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4Z2B COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-APR-15. REMARK 100 THE DEPOSITION ID IS D_1000208496. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-SEP-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E+ SUPERBRIGHT REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : MULTILAYER OPTICS REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU SATURN 944+ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 40745 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 91.9 REMARK 200 DATA REDUNDANCY : 4.800 REMARK 200 R MERGE (I) : 0.05400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.83 REMARK 200 COMPLETENESS FOR SHELL (%) : 66.1 REMARK 200 DATA REDUNDANCY IN SHELL : 2.10 REMARK 200 R MERGE FOR SHELL (I) : 0.26600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 2.5.1 REMARK 200 STARTING MODEL: 3NG0 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.07 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.32 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M TRIS PH 8.5 15% PEG20000 25% REMARK 280 ETHYLENE GLYCOL, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 28.15450 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 62.44000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 33.26600 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 62.44000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 28.15450 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 33.26600 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 TYR A 155 REMARK 465 LYS A 156 REMARK 465 VAL A 157 REMARK 465 GLU A 158 REMARK 465 ARG A 159 REMARK 465 ASN A 160 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP A 189 CG OD1 OD2 REMARK 470 LYS A 202 CE NZ REMARK 470 GLU A 291 CG CD OE1 OE2 REMARK 470 GLU A 573 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 303 104.92 64.05 REMARK 500 SER A 360 -58.25 -121.17 REMARK 500 LYS A 377 -81.99 -101.51 REMARK 500 LYS A 377 -81.39 -101.94 REMARK 500 GLN A 378 -65.83 -135.54 REMARK 500 LEU A 394 -61.21 -91.19 REMARK 500 HIS A 397 50.98 -141.45 REMARK 500 CYS A 530 55.07 -151.64 REMARK 500 GLN A 588 -61.10 72.13 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A1261 DISTANCE = 6.23 ANGSTROMS REMARK 525 HOH A1262 DISTANCE = 8.41 ANGSTROMS REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A 706 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 598 OD2 REMARK 620 2 4LC A 705 O18 109.9 REMARK 620 3 HOH A 828 O 80.5 161.6 REMARK 620 4 HOH A 847 O 125.6 80.2 81.4 REMARK 620 5 HOH A1038 O 74.7 103.9 93.4 157.2 REMARK 620 N 1 2 3 4 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 701 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 702 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 703 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue TRS A 704 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 4LC A 705 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MG A 706 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4Z0V RELATED DB: PDB REMARK 900 RELATED UNLIGANDED PROTEIN STRUCTURE DBREF 4Z2B A 155 609 UNP Q6L8Q7 PDE12_HUMAN 155 609 SEQRES 1 A 455 TYR LYS VAL GLU ARG ASN PRO PRO ALA PHE THR GLU LEU SEQRES 2 A 455 GLN LEU PRO ARG TYR ILE MET ALA GLY PHE PRO VAL CYS SEQRES 3 A 455 PRO LYS LEU SER LEU GLU PHE GLY ASP PRO ALA SER SER SEQRES 4 A 455 LEU PHE ARG TRP TYR LYS GLU ALA LYS PRO GLY ALA ALA SEQRES 5 A 455 GLU PRO GLU VAL GLY VAL PRO SER SER LEU SER PRO SER SEQRES 6 A 455 SER PRO SER SER SER TRP THR GLU THR ASP VAL GLU GLU SEQRES 7 A 455 ARG VAL TYR THR PRO SER ASN ALA ASP ILE GLY LEU ARG SEQRES 8 A 455 LEU LYS LEU HIS CYS THR PRO GLY ASP GLY GLN ARG PHE SEQRES 9 A 455 GLY HIS SER ARG GLU LEU GLU SER VAL CYS VAL VAL GLU SEQRES 10 A 455 ALA GLY PRO GLY THR CYS THR PHE ASP HIS ARG HIS LEU SEQRES 11 A 455 TYR THR LYS LYS VAL THR GLU ASP ALA LEU ILE ARG THR SEQRES 12 A 455 VAL SER TYR ASN ILE LEU ALA ASP THR TYR ALA GLN THR SEQRES 13 A 455 GLU PHE SER ARG THR VAL LEU TYR PRO TYR CYS ALA PRO SEQRES 14 A 455 TYR ALA LEU GLU LEU ASP TYR ARG GLN ASN LEU ILE GLN SEQRES 15 A 455 LYS GLU LEU THR GLY TYR ASN ALA ASP VAL ILE CYS LEU SEQRES 16 A 455 GLN GLU VAL ASP ARG ALA VAL PHE SER ASP SER LEU VAL SEQRES 17 A 455 PRO ALA LEU GLU ALA PHE GLY LEU GLU GLY VAL PHE ARG SEQRES 18 A 455 ILE LYS GLN HIS GLU GLY LEU ALA THR PHE TYR ARG LYS SEQRES 19 A 455 SER LYS PHE SER LEU LEU SER GLN HIS ASP ILE SER PHE SEQRES 20 A 455 TYR GLU ALA LEU GLU SER ASP PRO LEU HIS LYS GLU LEU SEQRES 21 A 455 LEU GLU LYS LEU VAL LEU TYR PRO SER ALA GLN GLU LYS SEQRES 22 A 455 VAL LEU GLN ARG SER SER VAL LEU GLN VAL SER VAL LEU SEQRES 23 A 455 GLN SER THR LYS ASP SER SER LYS ARG ILE CYS VAL ALA SEQRES 24 A 455 ASN THR HIS LEU TYR TRP HIS PRO LYS GLY GLY TYR ILE SEQRES 25 A 455 ARG LEU ILE GLN MET ALA VAL ALA LEU ALA HIS ILE ARG SEQRES 26 A 455 HIS VAL SER CYS ASP LEU TYR PRO GLY ILE PRO VAL ILE SEQRES 27 A 455 PHE CYS GLY ASP PHE ASN SER THR PRO SER THR GLY MET SEQRES 28 A 455 TYR HIS PHE VAL ILE ASN GLY SER ILE PRO GLU ASP HIS SEQRES 29 A 455 GLU ASP TRP ALA SER ASN GLY GLU GLU GLU ARG CYS ASN SEQRES 30 A 455 MET SER LEU THR HIS PHE PHE LYS LEU LYS SER ALA CYS SEQRES 31 A 455 GLY GLU PRO ALA TYR THR ASN TYR VAL GLY GLY PHE HIS SEQRES 32 A 455 GLY CYS LEU ASP TYR ILE PHE ILE ASP LEU ASN ALA LEU SEQRES 33 A 455 GLU VAL GLU GLN VAL ILE PRO LEU PRO SER HIS GLU GLU SEQRES 34 A 455 VAL THR THR HIS GLN ALA LEU PRO SER VAL SER HIS PRO SEQRES 35 A 455 SER ASP HIS ILE ALA LEU VAL CYS ASP LEU LYS TRP LYS HET SO4 A 701 5 HET EDO A 702 4 HET EDO A 703 4 HET TRS A 704 8 HET 4LC A 705 37 HET MG A 706 1 HETNAM SO4 SULFATE ION HETNAM EDO 1,2-ETHANEDIOL HETNAM TRS 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL HETNAM 4LC 3-(6-{[(2S,3S)-3-(HYDROXYMETHYL)-2-PHENYLMORPHOLIN-4- HETNAM 2 4LC YL]CARBONYL}-1-METHYL-1H-BENZIMIDAZOL-2-YL)-1H-INDOLE- HETNAM 3 4LC 6-CARBONITRILE HETNAM MG MAGNESIUM ION HETSYN EDO ETHYLENE GLYCOL HETSYN TRS TRIS BUFFER FORMUL 2 SO4 O4 S 2- FORMUL 3 EDO 2(C2 H6 O2) FORMUL 5 TRS C4 H12 N O3 1+ FORMUL 6 4LC C29 H25 N5 O3 FORMUL 7 MG MG 2+ FORMUL 8 HOH *462(H2 O) HELIX 1 AA1 ASP A 189 SER A 193 5 5 HELIX 2 AA2 PRO A 213 SER A 217 5 5 HELIX 3 AA3 SER A 238 ILE A 242 5 5 HELIX 4 AA4 THR A 278 LEU A 284 1 7 HELIX 5 AA5 ALA A 304 GLN A 309 1 6 HELIX 6 AA6 THR A 310 VAL A 316 1 7 HELIX 7 AA7 ALA A 322 LEU A 326 5 5 HELIX 8 AA8 GLU A 327 TYR A 342 1 16 HELIX 9 AA9 ASP A 353 SER A 360 1 8 HELIX 10 AB1 SER A 360 PHE A 368 1 9 HELIX 11 AB2 PHE A 401 ASP A 408 1 8 HELIX 12 AB3 HIS A 411 LEU A 420 1 10 HELIX 13 AB4 TYR A 421 GLN A 430 1 10 HELIX 14 AB5 GLY A 463 ASP A 484 1 22 HELIX 15 AB6 THR A 503 GLY A 512 1 10 HELIX 16 AB7 HIS A 518 SER A 523 5 6 HELIX 17 AB8 SER A 580 THR A 585 1 6 SHEET 1 AA1 2 ALA A 163 GLN A 168 0 SHEET 2 AA1 2 LYS A 182 GLU A 186 -1 O GLU A 186 N ALA A 163 SHEET 1 AA2 2 ILE A 173 MET A 174 0 SHEET 2 AA2 2 VAL A 270 GLU A 271 1 O GLU A 271 N ILE A 173 SHEET 1 AA3 4 TRP A 225 GLU A 227 0 SHEET 2 AA3 4 LEU A 194 GLU A 200 -1 N LYS A 199 O THR A 226 SHEET 3 AA3 4 LEU A 246 THR A 251 -1 O LYS A 247 N TYR A 198 SHEET 4 AA3 4 ARG A 262 GLU A 265 -1 O ARG A 262 N CYS A 250 SHEET 1 AA4 6 LEU A 370 ILE A 376 0 SHEET 2 AA4 6 GLY A 381 ARG A 387 -1 O LEU A 382 N ARG A 375 SHEET 3 AA4 6 VAL A 346 VAL A 352 -1 N LEU A 349 O ALA A 383 SHEET 4 AA4 6 LEU A 294 ASN A 301 1 N VAL A 298 O CYS A 348 SHEET 5 AA4 6 LEU A 602 TRP A 608 -1 O CYS A 604 N THR A 297 SHEET 6 AA4 6 LEU A 570 VAL A 575 -1 N GLU A 573 O ASP A 605 SHEET 1 AA5 3 PHE A 391 GLN A 396 0 SHEET 2 AA5 3 VAL A 434 SER A 442 -1 O VAL A 439 N SER A 395 SHEET 3 AA5 3 ILE A 399 SER A 400 -1 N ILE A 399 O LEU A 435 SHEET 1 AA6 6 PHE A 391 GLN A 396 0 SHEET 2 AA6 6 VAL A 434 SER A 442 -1 O VAL A 439 N SER A 395 SHEET 3 AA6 6 ARG A 449 HIS A 456 -1 O VAL A 452 N SER A 438 SHEET 4 AA6 6 VAL A 491 ASP A 496 1 O ILE A 492 N ALA A 453 SHEET 5 AA6 6 ASP A 561 ASP A 566 -1 O PHE A 564 N PHE A 493 SHEET 6 AA6 6 LEU A 540 SER A 542 -1 N LYS A 541 O ILE A 565 SHEET 1 AA7 2 SER A 513 ILE A 514 0 SHEET 2 AA7 2 LEU A 534 THR A 535 -1 O LEU A 534 N ILE A 514 SHEET 1 AA8 2 ASN A 551 TYR A 552 0 SHEET 2 AA8 2 HIS A 557 GLY A 558 -1 O GLY A 558 N ASN A 551 LINK OD2 ASP A 598 MG MG A 706 1555 1555 2.80 LINK O18 4LC A 705 MG MG A 706 1555 1555 2.68 LINK MG MG A 706 O HOH A 828 1555 1555 2.21 LINK MG MG A 706 O HOH A 847 1555 1555 2.19 LINK MG MG A 706 O HOH A1038 1555 1555 2.36 CISPEP 1 LEU A 590 PRO A 591 0 -7.76 SITE 1 AC1 9 GLU A 207 LYS A 377 ARG A 431 SER A 432 SITE 2 AC1 9 TYR A 458 EDO A 702 HOH A 822 HOH A 843 SITE 3 AC1 9 HOH A 893 SITE 1 AC2 7 LYS A 377 SER A 433 HIS A 456 LEU A 457 SITE 2 AC2 7 TYR A 458 TRP A 459 SO4 A 701 SITE 1 AC3 6 PHE A 177 PRO A 274 GLY A 275 CYS A 277 SITE 2 AC3 6 ASP A 280 LYS A 337 SITE 1 AC4 9 HIS A 281 LYS A 412 GLU A 416 SER A 580 SITE 2 AC4 9 GLU A 583 HOH A 818 HOH A 857 HOH A 936 SITE 3 AC4 9 HOH A1037 SITE 1 AC5 19 PRO A 208 GLU A 209 TYR A 307 THR A 310 SITE 2 AC5 19 SER A 313 GLU A 351 TRP A 459 PRO A 461 SITE 3 AC5 19 ASN A 498 SER A 499 THR A 500 THR A 503 SITE 4 AC5 19 PHE A 556 MG A 706 HOH A 842 HOH A 844 SITE 5 AC5 19 HOH A 920 HOH A 973 HOH A1098 SITE 1 AC6 6 GLU A 351 ASP A 598 4LC A 705 HOH A 828 SITE 2 AC6 6 HOH A 847 HOH A1038 CRYST1 56.309 66.532 124.880 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017759 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015030 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008008 0.00000